Selected publications

  1. Restelli V, Lupi M, Chilà R, Vagni M, Tarantelli C, Spriano F, Gaudio E, Bertoni F, Damia G, Carrassa L.
    DNA damage response inhibitor combinations exert synergistic antitumor activity in aggressive B cell lymphomas. (2019) Mol Cancer Ther; 18: 1255.
  2. Capasso Palmiero, U., Morosi, L., Lupi, M., Ponzo, M., Frapolli, R., Zucchetti, M., Ubezio, P., Morbidelli, M., D’Incalci, M., Bello, E., Moscatelli, D.
    Self-Assembling PCL-Based Nanoparticles as PTX Solubility Enhancer Excipients (2018) Macromolecular Bioscience, 18 (10), art. no. 1800164.
  3. Ubezio P, Falcetta F, Carrassa L, Lupi M. Integrated experimental and simulation study of the response to sequential treatment with erlotinib and gemcitabine in pancreatic cancer (2016) Oncotarget; 7: 15492.
  4. Lupi, M., Colombo, C., Frapolli, R., Ferrari, R., Sitia, L., Dragoni, L., Bello, E., Licandro, S.A., Falcetta, F., Ubezio, P., Bigini, P., Salmona, M., D’Incalci, M., Morbidelli, M., Moscatelli, D.
    A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma (2014) Nanotechnology, 25 (33), art. no. 335706.
  5. Ferrari, R., Lupi, M., Falcetta, F., Bigini, P., Paolella, K., Fiordaliso, F., Bisighini, C., Salmona, M., D’Incalci, M., Morbidelli, M., Moscatelli, D., Ubezio, P.
    Integrated multiplatform method for in vitro quantitative assessment of cellular uptake for fluorescent polymer nanoparticles (2014) Nanotechnology, 25 (4), art. no. 045102.
  6. Falcetta F, Lupi M, Colombo V, Ubezio P. Dynamic rendering of the heterogeneous cell response to anticancer treatments. (2013) PLoS Comput Biol; 9: e100329.
  7. Khan I A, Lupi M, Campbell L, Chappell S C, Brown M, Wiltshire M, Smith P J, Ubezio P, Errington R J. Interoperability of time series cytometric data: a cross platform approach for modeling tumor heterogeneity. (2011) Cytometry A; 79A: 214.
  8. Ubezio P, Lupi M, Branduardi D, Cappella P, Cavallini E, Colombo V, Matera G, Natoli C, Tomasoni D, D’Incalci M. Quantitative assessment of the complex dynamics of G1, S, and G2-M checkpoint activities. (2009) Cancer Res; 69: 5234.
  9. Lupi M, Matera G, Natoli C, Colombo V, Ubezio P. The contribution of p53 in the dynamics of cell cycle response to DNA damage interpreted by a mathematical model. (2007) Cell Cycle; 6: 943.
  10. Lupi M, Matera G, Branduardi D, D’Incalci M, Ubezio P. Cytostatic and cytotoxic effects of topotecan decoded by a novel mathematical simulation approach. (2004) Cancer Res; 64: 2825.